Cargando…
Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR
Lung cancer remains the leading cause of cancer-related mortality worldwide. The application of next-generation genomic technologies has offered a more comprehensive look at the mutational landscape across the different subtypes of non-small cell lung cancer (NSCLC). A number of recurrent mutations...
Autores principales: | Richer, Amanda L, Friel, Jacqueline M, Carson, Vashti M, Inge, Landon J, Whitsett, Timothy G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397718/ https://www.ncbi.nlm.nih.gov/pubmed/25897257 http://dx.doi.org/10.2147/PGPM.S52845 |
Ejemplares similares
-
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer
por: Yap, Timothy A, et al.
Publicado: (2014) -
Precision medicine gets an edge
Publicado: (2019) -
Precision medicine in Australia: now is the time to get it right
por: O'Shea, Rosie, et al.
Publicado: (2022) -
Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders
por: Lenze, Eric J., et al.
Publicado: (2021) -
Can precision medicine get us through menopause?
por: Vieira-Potter, Victoria J.
Publicado: (2022)